AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ribjop D 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Addii Biotech Pvt Ltd

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Ribjop D 30mg/20mg Capsule SR

Gastro-esophageal reflux disease (GERD), or acid reflux, can be managed with the combined-action capsules, RefluxAid 30mg/20mg SR. This medication targets acid reflux symptoms like heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion. RefluxAid 30mg/20mg SR should be taken as directed by your physician, on an empty stomach, with dosage tailored to your condition and response. Consistent use, as prescribed, is crucial; premature discontinuation may lead to symptom recurrence and disease exacerbation. Inform your doctor of all other medications you are using, as interactions are possible. Common, usually transient, side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring alertness until the drug's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding hot beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.

Uses of Ribjop D 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Ribjop D 30mg/20mg Capsule SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Ribjop D 30mg/20mg Extended-Release Capsules should be taken on an empty stomach.

Common Side effects of Ribjop D 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Ribjop D 30mg/20mg Capsule SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Ribjop D 30mg/20mg SR Capsule whole; do not break, crush, or chew it. Administer on an empty stomach.

How Ribjop D 30mg/20mg Capsule SR works:

Ribjop D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, acting synergistically to alleviate digestive issues. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid reflux and indigestion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Ribjop D 30mg/20mg SR capsules with alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Ribjop D 30mg/20mg capsule may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Ribjop D 30mg/20mg capsule is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Ribjop D 30mg/20mg sustained-release capsules may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Ribjop D 30mg/20mg sustained-release capsules. Dosage modification of Ribjop D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when taking Ribjop D 30mg/20mg SR capsules; dosage modification may be necessary. A physician's consultation is advised. Ribjop D 30mg/20mg SR capsules are unsuitable for individuals with moderate to severe hepatic dysfunction.

What if you forget to take Ribjop D 30mg/20mg Capsule SR :

Should you forget a Ribjop D 30mg/20mg Capsule SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ribjop D 30mg/20mg Capsule SR

LabelValue
Addictive None.
Type of Medication Digestive system

FAQs on Ribjop D 30mg/20mg Capsule SR

Ribjop D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This formulation addresses heartburn, acidity, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It's also indicated for gastric and duodenal ulcers. Domperidone's mechanism involves enhancing gut motility to facilitate smoother food passage through the stomach, thus managing vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any inactive components of Ribjop D 30mg/20mg Capsule SR should avoid its use. Individuals with pre-existing kidney or liver conditions require careful monitoring when considering this medication.
Indeed, Ribjop D 30mg/20mg SR Capsules may induce dry mouth, a side effect attributed to the Domperidone component. To alleviate this, increased water consumption is recommended. Keeping water readily available overnight is also helpful. Reducing alcohol intake and abstaining from smoking are advisable. For dry mouth, consider alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Ribjop D 30mg/20mg SR Capsules. If diarrhea occurs, increase fluid intake. Oily or fried foods should be avoided while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms appear, such as reduced urination and dark, strong-smelling urine.
Store the medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Ribjop D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience typical adverse reactions including diarrhea, abdominal discomfort, flatulence, dry mouth, vertigo, and cephalalgia, alongside less frequent or infrequent side effects. Report any ongoing issues to your physician during treatment.
Optimal absorption of Ribjop D 30mg/20mg sustained-release capsules is achieved by ingestion prior to the initial meal or while fasting.
Taking Ribjop D 30mg/20mg Capsule SR may raise the likelihood of experiencing an abnormal heart rhythm (serious arrhythmias). While this is a significant adverse effect, the probability of occurrence remains quite small. However, the risk might be marginally elevated for individuals over 60.
Ribjop D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation addresses heartburn, acid reflux (GERD), and ulcers affecting the stomach and duodenum. GERD is characterized by stomach acid regurgitation into the esophagus. Domperidone's mechanism involves boosting gut motility, facilitating efficient food transit through the stomach and thereby reducing nausea and vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any excipient within Ribjop D 30mg/20mg SR Capsules should avoid its use. Individuals with pre-existing hepatic or renal impairment require careful monitoring if prescribed this medication.
Indeed, Ribjop D 30mg/20mg SR Capsules may induce xerostomia. This side effect stems from the Domperidone component. To alleviate dry mouth, increase fluid consumption. Keep a water source readily available overnight. Reduce alcohol consumption and abstain from smoking. For dry mouth, utilize alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Ribjop D 30mg/20mg SR Capsules. If diarrhea occurs, increase fluid intake. Oily or greasy foods should be avoided while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms, such as reduced urination and dark, strong-smelling urine, appear.
Ribjop D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience adverse reactions, including, but not limited to, diarrhea, abdominal discomfort, flatulence, xerostomia, vertigo, and cephalalgia. Less frequent or infrequent side effects are also possible. Report any ongoing issues to your physician during treatment.
Optimal absorption of Ribjop D 30mg/20mg sustained-release capsules is achieved by taking them before breakfast or on an empty stomach.
Taking Ribjop D 30mg/20mg SR capsules may raise the likelihood of an abnormal heart rhythm (a serious arrhythmia). While this is a significant potential side effect, the probability of occurrence remains quite small. Individuals over 60 might face a marginally increased risk.
Store the medication in its original, tightly sealed container or packaging, following the storage instructions provided on the label. Discard any leftover medication and ensure it remains inaccessible to children, pets, and others.
Ribjop D 30mg/20mg Capsul...
71
MRP 86
17% off